GC
Geoffrey F Cox
Director

Geoffrey F Cox insider trades: Nabi Biopharmaceuticals (NABI) stock purchases

Director, Nabi Biopharmaceuticals Last trade May 20, 2010 53 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2005
8
Companies
last trade 2010

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Geoffrey reports to the SEC

and 2 more companies

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 20, 2010NABI↑ Buy$10K
Nov 21, 2008GTCB↑ Buy$14K
Mar 14, 2008GTCB↑ Buy$48K
Dec 13, 2007GTCB↑ Buy$10K
Aug 13, 2007GTCB↑ Buy$15K
Mar 14, 2007GTCB↑ Buy$24K
Nov 6, 2006GTCB↑ Buy$15K
May 4, 2005GTCB↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Geoffrey F Cox's insider trades

Geoffrey F Cox is a director at Nabi Biopharmaceuticals (NABI). Since May 4, 2005, Geoffrey has reported 8 open-market purchases worth $140K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (32 filings), other transactions (10 filings), option exercises (5 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NABI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.